Olema Pharmaceuticals (OLMA) Stock: Buy, Sell, or Hold?
OLMA - Olema Pharmaceuticals, Inc. Common Stock
$6.41
-0.61 (-8.69%)
▼
5d:
-2.58%
30d:
-29.09%
90d:
-46.63%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 09, 2026
15d
Get Alerted When OLMA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OLMA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OLMA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: OLMA is currently trading at $6.41, which is considered oversold relative to its 30-day fair value range of $7.11 to $9.35.
Technical Outlook: Technically, OLMA is in a strong downtrend. The price is currently testing key support at $6.24. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.7% recently.
Market Sentiment: OLMA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $36.50 (+469.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OLMA is in a strong downtrend. The price is currently testing key support at $6.24. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 8.7% recently.
Market Sentiment: OLMA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $36.50 (+469.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$7.11 -
$9.35
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding OLMA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-8.7%)
- BULLISH: Trading 469.4% below Wall St target ($36.50)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.11 -
$9.35
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$6.24
Resistance Level
$7.77
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.43
Wall Street Target
$36.50
(+469.4%)
Share & Embed Analysis
Last updated: October 23, 2026 9:53 PM ET
Data refreshes hourly during market hours. Next update: 10:53 PM
Data refreshes hourly during market hours. Next update: 10:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OLMA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
25 analysts |
$1153 | 52 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$139 | 49 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
17 analysts |
$141 | 52 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 47 HOLD |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$117 | 53 HOLD |
Advanced OLMA Option Strategies
Professional options setups generated by AI based on today's OLMA price and gamma walls.
